Arformoterol is the single (R,R)-enantiomer of formoterol, a long-acting beta-2 adrenergic agonist administered by nebulisation for the maintenance treatment of COPD. Simson Pharma's Arformoterol reference standard and impurities support stability-indicating testing for this single-enantiomer respiratory therapy.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Arformoterol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.